Search Results 1071-1080 of 17687 for Blind spot

  1. A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants with Moderately to Severely Active Crohn's Disease (CD) - Mayo Clinic

    This is a multicenter, Phase 3, double-blind, placebo-controlled study evaluating the efficacy, safety, and tolerability of etrolizumab compared with ...

  2. Efficacy, Safety, And Tolerability Study Of Lunsekimig Compared With Placebo In Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized By An Eosinophilic Phenotype PERSEPHONE - Mayo Clinic

    Efficacy, Safety, And Tolerability Study Of Lunsekimig Compared With Placebo In Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary ...

  3. Light Treatment Effectiveness (LITE) Study (LITE) - Mayo Clinic

    The purpose of this study is to compare the effectiveness, safety (tolerability), and duration of treatment response at 12 weeks of home versus office-based ...

  4. Biobank Protocol, Rare Diseases Clinical Research Network - Mayo Clinic

    Documented LMWP > 5x the upper reference range at any time point; AND at least ONE of the following criteria: Identified mutation of the CLCN5 gene (Dent 1) ...

  5. Brachial plexus injury - Doctors and departments - Mayo Clinic

    Basic and clinical research is being carried out in the area of peripheral nerve injury by scientists in neurology, neurosurgery and orthopedic surgery.

  6. Breast Imaging with Positron Emission Mammography - Mayo Clinic

    The objective of this study is to determine if the diagnostic performance of a dedicated breast-specific positron emission mammography (PEM) system, is superior ...

  7. A Databank Study of Molecular Circulatory Biomarkers in Non-localized Renal and Testicular Cancer Patients - Mayo Clinic

    The purpose of this study is to collect blood and urine specimens from cancer patients with non-localized kidney cancer receiving therapeutic interventions and ...

  8. A Study to Evaluate Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients with Chronic Myeloid Leukemia and Persistently- Detectable Minimal Residual Disease - Mayo Clinic

    ... point; 2)has not undergone a hysterectomy or bilateral oophorectomy; or 3) has not been naturally postmenopausal (amenorrhea following cancer therapy does ...

  9. Medical Research & Education - Mayo Clinic News Network

    Minnesota. MEDIA ADVISORY: Mayo Clinic Center for Regenerative Medicine and Rochester Area Economic Development, Inc. to Host Open House for Advanced Product ...

  10. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

    Rash must cover less than 10% of body surface area;; Disease is well controlled at baseline and only requiring low-potency topical steroids;; No acute ...